This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brady, M. Articles by Boyd, M. T. Search for Related Content PubMed PubMed Citation Articles by Brady, M. Articles by Boyd, M. T.

Regulation of p53 and MDM2 Activity by MTBP

Mark Brady, Nikolina Vlatkovi, and Mark T. Boyd^*

MDM2/p53 Laboratory, Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom

Received 17 March 2004/ Returned for modification 1 June 2004/ Accepted 15 October 2004

p53 is a critical coordinator of a wide range of stress responses. To facilitate a rapid response to stress, p53 is produced constitutively but is negatively regulated by MDM2. MDM2 can inhibit p53 in multiple independent ways: by binding to its transcription activation domain, inhibiting p53 acetylation, promoting nuclear export, and probably most importantly by promoting proteasomal degradation of p53. The latter is achieved via MDM2's E3 ubiquitin ligase activity harbored within the MDM2 RING finger domain. We have discovered that MTBP promotes MDM2-mediated ubiquitination and degradation of p53 and also MDM2 stabilization in an MDM2 RING finger-dependent manner. Moreover, using small interfering RNA to down-regulate endogenous MTBP in unstressed cells, we have found that MTBP significantly contributes to MDM2-mediated regulation of p53 levels and activity. However, following exposure of cells to UV, but not -irradiation, MTBP is destabilized as part of the coordinated cellular response. Our findings suggest that MTBP differentially regulates the E3 ubiquitin ligase activity of MDM2 towards two of its most critical targets (itself and p53) and in doing so significantly contributes to MDM2-dependent p53 homeostasis in unstressed cells.

M.B. and N.V. contributed equally to this work.

This article has been cited by other articles:

• Maguire, M., Nield, P. C., Devling, T., Jenkins, R. E., Park, B. K., Polanski, R., Vlatkovic, N., Boyd, M. T. (2008). MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination. Cancer Res. 68: 3232-3242 [Abstract] [Full Text]  
• Martin, E. S., Tonon, G., Sinha, R., Xiao, Y., Feng, B., Kimmelman, A. C., Protopopov, A., Ivanova, E., Brennan, C., Montgomery, K., Kucherlapati, R., Bailey, G., Redston, M., Chin, L., DePinho, R. A. (2007). Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types. Cancer Res. 67: 10736-10743 [Abstract] [Full Text]  
• Tabakin-Fix, Y., Azran, I., Schavinky-Khrapunsky, Y., Levy, O., Aboud, M. (2006). Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis 27: 673-681 [Abstract] [Full Text]  
• Warburton, H. E., Brady, M., Vlatkovic, N., Linehan, W. M., Parsons, K., Boyd, M. T. (2005). p53 Regulation and Function in Renal Cell Carcinoma. Cancer Res. 65: 6498-6503 [Abstract] [Full Text]